RhAPPcast: Treat-to-Target in SLE: DORIS Remission Real in Practice episode artwork

EPISODE · Jul 9, 2026 · 35 MIN

RhAPPcast: Treat-to-Target in SLE: DORIS Remission Real in Practice

from RhAPPcast

In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon, PA-C, is joined by Heather Finlayson, PA-C, to discuss treat-to-target strategies in lupus management and how DORIS remission can be applied in real-world clinical practice. This conversation explores what successful lupus care looks like beyond flare management, including steroid minimization, low disease activity, shared decision-making, and the use of objective tools such as SLEDAI-2K to monitor disease activity. Listeners will gain practical insights on setting realistic remission goals, reducing long-term prednisone burden, recognizing when to escalate therapy, and helping patients understand that remission in systemic lupus erythematosus means stable disease control on therapy. Designed for rheumatology APPs and clinicians, this episode offers actionable strategies to improve lupus outcomes, support patient-centered care, and bring treat-to-target goals into everyday practice.

Episode metadata supplied by the publisher feed · Published Jul 9, 2026

Embed this episode

NOW PLAYING

RhAPPcast: Treat-to-Target in SLE: DORIS Remission Real in Practice

0:00 35:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of RhAPPcast?

This episode is 35 minutes long.

When was this RhAPPcast episode published?

This episode was published on July 9, 2026.

Can I download this RhAPPcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!